Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Penumbra (PEN) Research & Development (2016 - 2026)

Penumbra has reported Research & Development over the past 12 years, most recently at $21.8 million for Q4 2025.

  • Quarterly Research & Development rose 8.92% to $21.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.8 million through Dec 2025, down 5.29% year-over-year, with the annual reading at $89.8 million for FY2025, 5.29% down from the prior year.
  • Research & Development was $21.8 million for Q4 2025 at Penumbra, down from $22.7 million in the prior quarter.
  • Over five years, Research & Development peaked at $52.0 million in Q4 2021 and troughed at $16.7 million in Q3 2021.
  • The 5-year median for Research & Development is $21.4 million (2022), against an average of $22.6 million.
  • Year-over-year, Research & Development skyrocketed 167.3% in 2021 and then tumbled 65.46% in 2022.
  • A 5-year view of Research & Development shows it stood at $52.0 million in 2021, then crashed by 65.46% to $18.0 million in 2022, then rose by 22.14% to $21.9 million in 2023, then fell by 8.81% to $20.0 million in 2024, then increased by 8.92% to $21.8 million in 2025.
  • Per Business Quant, the three most recent readings for PEN's Research & Development are $21.8 million (Q4 2025), $22.7 million (Q3 2025), and $23.2 million (Q2 2025).